W. Dai

Preclinical assessment of the feasibility of applying controlled release oral drug delivery to a lead series of atypical antipsychotics.

A. Megens, W. van Osdol, J. Scicinski, 2006, Journal of pharmaceutical sciences.

Fabrication and Evaluation of Curcumin-loaded Nanoparticles Based on Solid Lipid as a New Type of Colloidal Drug Delivery System

H. Xing, W. Dai, J. Chen, 2013, Indian journal of pharmaceutical sciences.

Connectivity-Aware Contract for Incentivizing IoT Devices in Complex Wireless Blockchain

Jiawen Kang, W. Dai, Jin Chen, 2022, IEEE Internet of Things Journal.

Two Pairs of Isomerically New Phenylpropanoidated Epicatechin Gallates with Neuroprotective Effects on H2O2-Injured SH-SY5Y Cells from Zijuan Green Tea and Their Changes in Fresh Tea Leaves Collected from Different Months and Final Product.

Fenglin Hu, W. Dai, Gang-Xiu Chu, 2019, Journal of agricultural and food chemistry.

Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers

Weidong Chen, W. Dai, Fengling Wang, 2017, Acta pharmaceutica.

Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway

Weidong Chen, W. Dai, Fengling Wang, 2020, Acta pharmaceutica.

The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.

Weidong Chen, W. Dai, Fengling Wang, 2015, Journal of cancer research and therapeutics.